Phidea Marvin

Phidea Marvin S.r.l. is a CRO specializing in Phase I to IV clinical trials. It provides drug development services to companies seeking a single source for clinical research, including the design and management of pan-European clinical trials (Phase I-III) and post-marketing studies (Phase IV). Phidea Marvin S.r.l. focuses on cardiovascular, central nervous system, gastroenterology, oncology, rheumatology, and anti-infective research, serving a wide range of multinational pharmaceutical companies.